IMMX financials
Immix Biopharma (IMMX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
IMMX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$29.96M | -$29.44M | -0.89 |
| 2024 | $0.00 | $0.00 | -$22.67M | -$21.61M | -0.76 |
| 2023 | $0.00 | $0.00 | -$16.14M | -$15.43M | -0.89 |
| 2022 | $0.00 | $0.00 | -$8.22M | -$8.23M | -0.59 |
| 2021 | $0.00 | $0.00 | -$1.35M | -$24.38M | -6.64 |
| 2020 | $0.00 | $0.00 | -$453.85K | -$1.15M | -0.15 |